130 related articles for article (PubMed ID: 5684392)
1. The effect of neuroleptic drug treatment on plasma fibrinogen concentrations in schizophrenic states.
Brackenridge CJ; Jones IH
J Neurol Neurosurg Psychiatry; 1968 Aug; 31(4):326-9. PubMed ID: 5684392
[No Abstract] [Full Text] [Related]
2. Relation of hypermagnesaemia to activity and neuroleptic drug therapy in schizophrenic states.
Brackenridge CJ; Jones IH
J Neurol Neurosurg Psychiatry; 1971 Apr; 34(2):195-9. PubMed ID: 5571604
[TBL] [Abstract][Full Text] [Related]
3. Megavitamin B-3 therapy for schizophrenia.
Hoffer A
Can Psychiatr Assoc J; 1971 Dec; 16(6):499-504. PubMed ID: 4947171
[No Abstract] [Full Text] [Related]
4. [The factors influencing the effectiveness of therapy in schizophrenia and the principles of patient selection for a comparative evaluation of the results of treatment (a survey of the literature)].
Karimov RK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):612-9. PubMed ID: 4574524
[No Abstract] [Full Text] [Related]
5. Serum calcium and magnesium in schizophrenia: relationship to clinical phenomena and neuroleptic treatment.
Alexander PE; Van Kammen DP; Bunney WE
Br J Psychiatry; 1978 Aug; 133():143-9. PubMed ID: 354732
[TBL] [Abstract][Full Text] [Related]
6. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
[No Abstract] [Full Text] [Related]
7. An evaluation of the efficacy of oxypertine in acute and choronic schizophrenic patients.
Muniz AF; Terra SO; Bueno JR; Vianna Filho U
J Bras Psiquiatr; 1968; 17(1):83-95. PubMed ID: 5760628
[No Abstract] [Full Text] [Related]
8. A pilot-study of thiothixene in childhood schizophrenia.
Wolpert A; Hagamen MB; Merlis S
Curr Ther Res Clin Exp; 1966 Dec; 8(12):617-20. PubMed ID: 4962733
[No Abstract] [Full Text] [Related]
9. A comparative study of thiothixene and trifluoperazine in childhood schizophrenia.
Wolpert A; Hagamen MB; Merlis S
Curr Ther Res Clin Exp; 1967 Sep; 9(9):482-5. PubMed ID: 4963982
[No Abstract] [Full Text] [Related]
10. Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patient.
Biederman J; Rimon R; Ebstein R; Zohar J; Belmaker R
Neuropsychobiology; 1976; 2(5-6):324-7. PubMed ID: 197445
[TBL] [Abstract][Full Text] [Related]
11. [Psychopathology of schizophrenia in children and adolescents in relation to psychopharmacotherapy (author's transl)].
Pogády J; Hasko L
Cesk Psychiatr; 1975 Dec; 71(6):353-9. PubMed ID: 1218426
[No Abstract] [Full Text] [Related]
12. Evaluation of clinical efficacy of pimozide as maintenance therapy in chronic schizophrenic patients.
Singh AN
Curr Ther Res Clin Exp; 1971 Nov; 13(11):695-705. PubMed ID: 5000717
[No Abstract] [Full Text] [Related]
13. [Report on the clinical testing of the delayed-action form of the neuroleptic agent moperone hydrochloride in 20 chronic psychotic patients].
Lydecken K
Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(1):75-82. PubMed ID: 323966
[TBL] [Abstract][Full Text] [Related]
14. The schizophrenias: medical diagnosis and treatment by the family physician.
Donlon PT
J Fam Pract; 1978 Jun; 6(1):71-82. PubMed ID: 621484
[TBL] [Abstract][Full Text] [Related]
15. Neurological consequences of psychotropic drug withdrawal in schizophrenic children.
Polizos P; Engelhardt DM; Hoffman SP; Waizer J
J Autism Child Schizophr; 1973; 3(3):247-53. PubMed ID: 4800390
[No Abstract] [Full Text] [Related]
16. Clinical experience with octoclothepin in schizophrenic psychoses.
Zapletálek M; Ríkovský S; Barboráková E
Act Nerv Super (Praha); 1970 Jan; 12(1):45-6. PubMed ID: 5418654
[No Abstract] [Full Text] [Related]
17. [Blood serum tryptophan in schizophrenic patients and the dependence of its level on treatment with neuroleptics].
Szafranek J
Ann Acad Med Stetin; 1970; 16():519-34. PubMed ID: 5525985
[No Abstract] [Full Text] [Related]
18. Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients.
Zwanikken GJ; Remans B; Dewulf P; Amery W
Acta Psychiatr Scand; 1971; 47(3):334-48. PubMed ID: 4946910
[No Abstract] [Full Text] [Related]
19. Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
Haider I
J Pak Med Assoc; 1985 Sep; 35(9):286-9. PubMed ID: 3934417
[No Abstract] [Full Text] [Related]
20. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
Svestka J; Náhunek K
Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
